KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
KLRS
85 hedge funds and large institutions have $192M invested in Kalaris Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 15 closing their positions.
Holders
85
Holders Change
–
Holders Change %
0%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
36
Reduced
18
Closed
15
Calls
$110K
Puts
$81K
Net Calls
+$29K
Net Calls Change
-$58K
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$4.94M |
| 2 |
2
BlackRock
New York
|
$14.5M |
| 3 |
3
Massachusetts Financial Services
Boston,
Massachusetts
|
$5.03M |
| 4 |
4
Renaissance Technologies
New York
|
$2.12M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$399K |
